A vial of the Moderna Covid-19 vaccine and syringes sit prepared at a pop up vaccine clinic at the Jewish Community Center on April 16, 2021 in the Staten Island borough of New York City. Moderna is ...
Both Moderna MRNA and BioNTech BNTX are leading biotechs at the forefront of messenger RNA (mRNA) technology. The companies rose to prominence with their respective COVID-19 vaccines, but their ...
Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA (mRNA) name is pulling well ahead of the pack. Moderna (NASDAQ:MRNA | MRNA ...
Moderna's NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index funds ...
LNPs have been a frequent point of contention in the mire of patent litigation that has sprung up around mRNA vaccine technology following the approvals of Pfizer’s and Moderna’s products. (iStock / ...
The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech, and Novavax. The agency gave a green light to supplemental biologics license ...
26d
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...
Moderna is suing its chief competitor in the COVID-19 vaccine space, alleging that Pfizer and BioNTech stole key technology used in the development of that group's inoculation. Both Moderna and the ...
The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech. The agency gave a green light to supplemental biologics license applications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results